These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 20101746)

  • 1. Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance?
    Angulo P
    Hepatology; 2010 Feb; 51(2):373-5. PubMed ID: 20101746
    [No Abstract]   [Full Text] [Related]  

  • 2. Will the increased prevalence of nonalcoholic steatohepatitis (NASH) in the age of better hepatitis C virus therapy make NASH the deadlier disease?
    Rinella ME
    Hepatology; 2011 Oct; 54(4):1118-20. PubMed ID: 21956705
    [No Abstract]   [Full Text] [Related]  

  • 3. Evolution of nonalcoholic fatty liver disease recurrence after liver transplantation.
    Patil DT; Yerian LM
    Liver Transpl; 2012 Oct; 18(10):1147-53. PubMed ID: 22740341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality.
    Younossi ZM; Stepanova M; Rafiq N; Makhlouf H; Younoszai Z; Agrawal R; Goodman Z
    Hepatology; 2011 Jun; 53(6):1874-82. PubMed ID: 21360720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality in nonalcoholic fatty liver disease: clues from the Cremona study.
    Adams LA
    Hepatology; 2011 Jul; 54(1):6-8. PubMed ID: 21618568
    [No Abstract]   [Full Text] [Related]  

  • 6. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
    Matteoni CA; Younossi ZM; Gramlich T; Boparai N; Liu YC; McCullough AJ
    Gastroenterology; 1999 Jun; 116(6):1413-9. PubMed ID: 10348825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.
    Malik SM; Devera ME; Fontes P; Shaikh O; Sasatomi E; Ahmad J
    Liver Transpl; 2009 Dec; 15(12):1843-51. PubMed ID: 19938117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.
    Hui JM; Kench JG; Chitturi S; Sud A; Farrell GC; Byth K; Hall P; Khan M; George J
    Hepatology; 2003 Aug; 38(2):420-7. PubMed ID: 12883486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of NAFLD: remarkably benign in the absence of cirrhosis.
    Day CP
    Gastroenterology; 2005 Jul; 129(1):375-8. PubMed ID: 16012969
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term follow-up of patients with NAFLD and elevated liver enzymes.
    Ekstedt M; Franzén LE; Mathiesen UL; Thorelius L; Holmqvist M; Bodemar G; Kechagias S
    Hepatology; 2006 Oct; 44(4):865-73. PubMed ID: 17006923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Brown GT; Kleiner DE
    Metabolism; 2016 Aug; 65(8):1080-6. PubMed ID: 26775559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should nonalcoholic fatty liver disease be regarded as a hepatic illness only?
    Tarantino G
    World J Gastroenterol; 2007 Sep; 13(35):4669-72. PubMed ID: 17729388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosing steatohepatitis and predicting liver-related mortality in patients with NAFLD: two distinct concepts.
    Angulo P
    Hepatology; 2011 Jun; 53(6):1792-4. PubMed ID: 21557278
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognosis in nonalcoholic steatohepatitis.
    Propst A; Propst T; Judmaier G; Vogel W
    Gastroenterology; 1995 May; 108(5):1607. PubMed ID: 7729661
    [No Abstract]   [Full Text] [Related]  

  • 15. [Consequences of non-alcoholic fatty liver disease still unclear].
    Jansen PL
    Ned Tijdschr Geneeskd; 2012; 156(9):A4568. PubMed ID: 22373558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic fatty liver disease.
    Younossi ZM
    Curr Gastroenterol Rep; 1999; 1(1):57-62. PubMed ID: 10980928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic effect of steatosis on hepatocellular carcinoma patients after liver resection.
    Wu TH; Yu MC; Chan KM; Lee CF; Chen TC; Chang HC; Chou HS; Wu TJ; Eldeen FZ; Chen MF; Lee WC
    Eur J Surg Oncol; 2011 Jul; 37(7):618-22. PubMed ID: 21640545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic, cardiovascular, and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease.
    Rubinstein E; Lavine JE; Schwimmer JB
    Semin Liver Dis; 2008 Nov; 28(4):380-5. PubMed ID: 18956294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the outcome of nonalcoholic steatohepatitis? It's time to get serious.
    Ratziu V; Poynard T
    Hepatology; 2006 Oct; 44(4):802-5. PubMed ID: 17006914
    [No Abstract]   [Full Text] [Related]  

  • 20. Obesity and nonalcoholic fatty liver disease.
    Angulo P
    Nutr Rev; 2007 Jun; 65(6 Pt 2):S57-63. PubMed ID: 17605315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.